BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2268550)

  • 1. Influence of culture conditions on the estrogenic cell growth stimulation of human breast cancer cells.
    Ruedl C; Cappelletti V; Coradini D; Granata G; Di Fronzo G
    J Steroid Biochem Mol Biol; 1990 Oct; 37(2):195-200. PubMed ID: 2268550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
    Murphy CS; Pink JJ; Jordan VC
    Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF.
    Gill PG; Tilley WD; De Young NJ; Lensink IL; Dixon PD; Horsfall DJ
    Breast Cancer Res Treat; 1991 Dec; 20(1):53-62. PubMed ID: 1813069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the estradiol-17 beta mitogenic effect on human breast cancer MCF-7 cells by serum albumin in defined medium.
    Germain P; Harbrioux G
    Anticancer Res; 1993; 13(5A):1581-5. PubMed ID: 7694540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen.
    van der Burg B; Rutteman GR; Blankenstein MA; de Laat SW; van Zoelen EJ
    J Cell Physiol; 1988 Jan; 134(1):101-8. PubMed ID: 3275677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
    Karey KP; Sirbasku DA
    Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of estrogen growth response in MCF-7 cells.
    Wiese TE; Kral LG; Dennis KE; Butler WB; Brooks SC
    In Vitro Cell Dev Biol; 1992; 28A(9-10):595-602. PubMed ID: 1429362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth control of human mammary cancer cells (MCF-7 cells) in culture: effect of estradiol and growth factors in serum-containing medium.
    Aakvaag A; Utaaker E; Thorsen T; Lea OA; Lahooti H
    Cancer Res; 1990 Dec; 50(24):7806-10. PubMed ID: 2253223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of estrogen action on the proliferation of MCF-7 human breast cancer cells in an improved culture medium.
    Furuya Y; Kohno N; Fujiwara Y; Saitoh Y
    Cancer Res; 1989 Dec; 49(23):6670-4. PubMed ID: 2819716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture.
    Biswas R; Vonderhaar BK
    Cancer Res; 1987 Jul; 47(13):3509-14. PubMed ID: 3581086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
    Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
    Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture.
    Darbre PD; Curtis S; King RJ
    Cancer Res; 1984 Jul; 44(7):2790-3. PubMed ID: 6722808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.
    Sirbasku DA; Moreno-Cuevas JE
    In Vitro Cell Dev Biol Anim; 2000; 36(7):428-46. PubMed ID: 11039494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG).
    Fortunati N; Fissore F; Fazzari A; Piovano F; Catalano MG; Becchis M; Berta L; Frairia R
    J Steroid Biochem Mol Biol; 1999; 70(1-3):73-80. PubMed ID: 10529004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new serum-free method of measuring growth factor activities for human breast cancer cells in culture.
    Ogasawara M; Sirbasku DA
    In Vitro Cell Dev Biol; 1988 Sep; 24(9):911-20. PubMed ID: 3049518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine regulation of cell proliferation by estradiol and hydroxytamoxifen of transformed mouse Leydig cells in serum-free culture.
    Nishizawa Y; Sato B; Miyashita Y; Tsukada S; Hirose T; Kishimoto S; Matsumoto K
    Endocrinology; 1988 Jan; 122(1):227-35. PubMed ID: 3275537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth medium for the evaluation of antiestrogenic compounds in MCF-7 cell culture.
    Jain PT; Pento JT
    Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):595-8. PubMed ID: 1787766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of fetal calf serum in combination with pharmacological doses of progesterone or estradiol on proliferation and cell cycle kinetics of cultured mammary cancer cells.
    Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL
    Oncology; 1989; 46(6):391-9. PubMed ID: 2587005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.